Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The BAG-1 cochaperone is a negative regulator of p73-dependent transcription.

Wang XH, O'Connor D, Brimmell M, Packham G.

Br J Cancer. 2009 Apr 21;100(8):1347-57. doi: 10.1038/sj.bjc.6604985. Epub 2009 Mar 17.

2.

The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.

Lapham A, Adams JE, Paterson A, Lee M, Brimmell M, Packham G.

Gene. 2009 Mar 1;432(1-2):112-7. doi: 10.1016/j.gene.2008.12.002. Epub 2008 Dec 16.

PMID:
19124064
3.

Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells.

Lee M, Lapham A, Brimmell M, Wilkinson H, Packham G.

Apoptosis. 2008 Aug;13(8):972-82. doi: 10.1007/s10495-008-0229-2.

PMID:
18543107
4.

Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage.

Michels J, O'Neill JW, Dallman CL, Mouzakiti A, Habens F, Brimmell M, Zhang KY, Craig RW, Marcusson EG, Johnson PW, Packham G.

Oncogene. 2004 Jun 17;23(28):4818-27.

PMID:
15122313
5.

BAG-1 in carcinogenesis.

Sharp A, Crabb SJ, Townsend PA, Cutress RI, Brimmell M, Wang XH, Packham G.

Expert Rev Mol Med. 2004 Mar 22;6(7):1-15. Review.

PMID:
15033003
6.

Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor.

Yurek-George A, Habens F, Brimmell M, Packham G, Ganesan A.

J Am Chem Soc. 2004 Feb 4;126(4):1030-1.

PMID:
14746465
7.

The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription.

Cutress RI, Townsend PA, Sharp A, Maison A, Wood L, Lee R, Brimmell M, Mullee MA, Johnson PW, Royle GT, Bateman AC, Packham G.

Oncogene. 2003 Aug 7;22(32):4973-82.

PMID:
12902980
8.

BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway.

Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G.

Cancer Res. 2003 Jul 15;63(14):4150-7.

9.

BAG-1: a multifunctional regulator of cell growth and survival.

Townsend PA, Cutress RI, Sharp A, Brimmell M, Packham G.

Biochim Biophys Acta. 2003 Mar 17;1603(2):83-98.

PMID:
12618309
10.

BAG-1 expression and function in human cancer.

Cutress RI, Townsend PA, Brimmell M, Bateman AC, Hague A, Packham G.

Br J Cancer. 2002 Oct 7;87(8):834-9. Review.

11.

Identification of a novel human BCL-X promoter and exon.

MacCarthy-Morrogh L, Wood L, Brimmell M, Johnson PW, Packham G.

Oncogene. 2000 Nov 16;19(48):5534-8.

12.

Bcl-2-related proteins and cancer.

MacCarthy-Morrogh L, Mouzakiti A, Townsend P, Brimmell M, Packham G.

Biochem Soc Trans. 1999 Dec;27(6):785-9. Review. No abstract available.

PMID:
10830102
13.

High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers.

Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR, Packham G.

Br J Cancer. 1999 Nov;81(6):1042-51.

14.

Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.

Spender LC, Cannell EJ, Hollyoake M, Wensing B, Gawn JM, Brimmell M, Packham G, Farrell PJ.

J Virol. 1999 Jun;73(6):4678-88.

16.
17.

Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines.

Sinclair AJ, Jacquemin MG, Brooks L, Shanahan F, Brimmell M, Rowe M, Farrell PJ.

Virology. 1994 Mar;199(2):339-53.

PMID:
8122366
18.

Strain variation in Epstein-Barr virus immediate early genes.

Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ.

Virology. 1993 Feb;192(2):541-50.

PMID:
8093650
20.

Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.

Rooney CM, Brimmell M, Buschle M, Allan G, Farrell PJ, Kolman JL.

J Virol. 1992 Jan;66(1):496-504.

21.

Pathways of activation of the Epstein-Barr virus productive cycle.

Sinclair AJ, Brimmell M, Shanahan F, Farrell PJ.

J Virol. 1991 May;65(5):2237-44.

Supplemental Content

Loading ...
Support Center